Aesica Pharmaceuticals has secured a majority investment from private equity firm Silverfleet Capital, providing more capacity to expand operations in the UK and Europe.
Financial support will be provided by Lloyds Bank Corporate Markets Acquisition Finance, HSBC and Yorkshire Bank and additional corporate support will continue to be supplied by PricewaterhouseCoopers, Ernst & Young and Ward Hadaway. The pharmaceutical manufacturer, which has operations in a several UK locations as well as Germany and Italy, said in a statement that…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
